Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer.

Heo GS, Detering L, Luehmann HP, Primeau T, Lee YS, Laforest R, Li S, Stec J, Lim KH, Lockhart AC, Liu Y.

Mol Pharm. 2019 Sep 3;16(9):3996-4006. doi: 10.1021/acs.molpharmaceut.9b00653. Epub 2019 Aug 16.

PMID:
31369274
3.

Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia.

Ghobadi A, Miller CA, Li T, O'Laughlin M, Lee YS, Ali M, Westervelt P, DiPersio JF, Wartman L.

Haematologica. 2019 Aug;104(8):e373-e375. doi: 10.3324/haematol.2019.217794. Epub 2019 Mar 28. No abstract available.

4.

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies.

Ruzinova MB, Lee YS, Duncavage EJ, Welch JS.

Haematologica. 2019 Aug;104(8):e345-e348. doi: 10.3324/haematol.2018.205302. Epub 2019 Feb 21. No abstract available.

5.

Hepatic topographical changes of endoplasmic reticulum stress and unfolded protein response signaling after hemorrhagic shock and reperfusion.

Wolpert A, Obert D, Frey B, Lee YS, Korff S.

J Surg Res. 2018 Nov;231:278-289. doi: 10.1016/j.jss.2018.05.060. Epub 2018 Jun 23.

PMID:
30278941
6.

A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion.

Miller CA, Tricarico C, Skidmore ZL, Uy GL, Lee YS, Hassan A, O'Laughlin MD, Schmidt H, Tian L, Duncavage EJ, Griffith M, Griffith OL, Welch JS, Wartman LD.

Blood Adv. 2018 Jun 12;2(11):1295-1299. doi: 10.1182/bloodadvances.2017014183. No abstract available.

7.

Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Lee YS, Liu J, Fricano KA, Webb EM, Toolsie DR, Jones S, Rhoads JA, Vij R, Cashen AF, Abboud CN, Westervelt P, Bartlett NL, Dipersio JF, Kreisel FH, Lim KH.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2199-2204. doi: 10.1016/j.bbmt.2017.08.022. Epub 2017 Aug 26.

8.

Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy.

Duncavage EJ, Uy GL, Petti AA, Miller CA, Lee YS, Tandon B, Gao F, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Jacoby MA, Cashen AF, Wartman LD, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ, Welch JS.

Blood. 2017 Mar 9;129(10):1397-1401. doi: 10.1182/blood-2016-10-745273. Epub 2017 Jan 12. No abstract available.

9.

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ.

N Engl J Med. 2016 Nov 24;375(21):2023-2036. doi: 10.1056/NEJMoa1605949.

10.

Tlr2 on Bone Marrow and Non-Bone Marrow Derived Cells Regulates Inflammation and Organ Injury in Cooperation with Tlr4 During Resuscitated Hemorrhagic Shock.

Korff S, Loughran P, Cai C, Fan J, Elson G, Shang L, Pires SS, Lee YS, Guardado J, Scott M, Billiar TR.

Shock. 2016 Nov;46(5):519-526.

11.

Polarization properties of strongly coupled exchange-split excitons and pillar microcavities.

Lee YS.

Opt Lett. 2016 Oct 1;41(19):4550-4553. doi: 10.1364/OL.41.004550.

PMID:
27749878
12.

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.

Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA, Schappe T, Leong JW, Abdel-Latif S, Schneider SE, Willey S, Neal CC, Yu L, Oh ST, Lee YS, Mulder A, Claas F, Cooper MA, Fehniger TA.

Sci Transl Med. 2016 Sep 21;8(357):357ra123. doi: 10.1126/scitranslmed.aaf2341.

13.

Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL.

Luo H, Schmidt JA, Lee YS, Oltz EM, Payton JE.

Leuk Lymphoma. 2017 Feb;58(2):445-456. Epub 2016 Jun 7.

14.

Transient dual-energy lasing in a semiconductor microcavity.

Hsu FK, Xie W, Lee YS, Lin SD, Lai CW.

Sci Rep. 2015 Oct 19;5:15347. doi: 10.1038/srep15347.

15.

Method to evaluate afterpulsing probability in single-photon avalanche diodes.

Tzou BW, Wu JY, Lee YS, Lin SD.

Opt Lett. 2015 Aug 15;40(16):3774-7. doi: 10.1364/OL.40.003774.

PMID:
26274657
16.

Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome.

Lee YS, Filie A, Arthur D, Fojo AT, Jaffe ES.

Histopathology. 2015 Dec;67(6):925-7. doi: 10.1111/his.12737. Epub 2015 Jun 18. No abstract available.

17.

Role of incoherent pumping in a strongly coupled system of exchange-split excitons and pillar-microcavities.

Lee YS, Lin SD.

Opt Lett. 2014 Dec 1;39(23):6640-3. doi: 10.1364/OL.39.006640.

PMID:
25490641
18.

High-quality planar light emitting diode formed by induced two-dimensional electron and hole gases.

Dai VT, Lin SD, Lin SW, Lee YS, Zhang YJ, Li LC, Lee CP.

Opt Express. 2014 Feb 24;22(4):3811-7. doi: 10.1364/OE.22.003811.

PMID:
24663701
19.

SALL4 expression in germ cell and non-germ cell tumors: a systematic immunohistochemical study of 3215 cases.

Miettinen M, Wang Z, McCue PA, Sarlomo-Rikala M, Rys J, Biernat W, Lasota J, Lee YS.

Am J Surg Pathol. 2014 Mar;38(3):410-20. doi: 10.1097/PAS.0000000000000116.

20.

Polarized emission of quantum dots in microcavity and anisotropic Purcell factors.

Lee YS, Lin SD.

Opt Express. 2014 Jan 27;22(2):1512-23. doi: 10.1364/OE.22.001512.

PMID:
24515158

Supplemental Content

Loading ...
Support Center